GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $401,000 | 0.0% | 9,205 | 0.0% | 0.04% | +16.1% |
| Q1 2022 | $401,000 | -10.7% | 9,205 | -9.5% | 0.03% | 0.0% |
| Q4 2021 | $449,000 | +22.7% | 10,172 | +6.3% | 0.03% | +3.3% |
| Q3 2021 | $366,000 | -3.9% | 9,570 | 0.0% | 0.03% | 0.0% |
| Q2 2021 | $381,000 | +11.4% | 9,570 | 0.0% | 0.03% | -6.2% |
| Q1 2021 | $342,000 | -2.8% | 9,570 | 0.0% | 0.03% | -13.5% |
| Q4 2020 | $352,000 | -2.2% | 9,570 | 0.0% | 0.04% | -11.9% |
| Q3 2020 | $360,000 | -7.7% | 9,570 | 0.0% | 0.04% | -17.6% |
| Q2 2020 | $390,000 | -2.0% | 9,570 | -8.9% | 0.05% | -13.6% |
| Q1 2020 | $398,000 | -19.4% | 10,505 | 0.0% | 0.06% | +13.5% |
| Q4 2019 | $494,000 | +10.3% | 10,505 | 0.0% | 0.05% | +4.0% |
| Q3 2019 | $448,000 | +6.7% | 10,505 | 0.0% | 0.05% | +4.2% |
| Q2 2019 | $420,000 | -4.3% | 10,505 | 0.0% | 0.05% | -5.9% |
| Q1 2019 | $439,000 | +9.5% | 10,505 | 0.0% | 0.05% | -1.9% |
| Q4 2018 | $401,000 | -13.2% | 10,505 | -8.7% | 0.05% | 0.0% |
| Q3 2018 | $462,000 | +9.2% | 11,505 | +9.5% | 0.05% | +6.1% |
| Q2 2018 | $423,000 | +3.2% | 10,505 | 0.0% | 0.05% | 0.0% |
| Q1 2018 | $410,000 | +9.9% | 10,505 | 0.0% | 0.05% | +8.9% |
| Q4 2017 | $373,000 | -13.9% | 10,505 | -1.4% | 0.04% | -18.2% |
| Q3 2017 | $433,000 | -5.3% | 10,655 | +0.5% | 0.06% | -9.8% |
| Q2 2017 | $457,000 | +2.2% | 10,605 | 0.0% | 0.06% | -1.6% |
| Q1 2017 | $447,000 | +9.6% | 10,605 | 0.0% | 0.06% | +1.6% |
| Q4 2016 | $408,000 | +14.9% | 10,605 | +28.9% | 0.06% | -3.2% |
| Q3 2016 | $355,000 | +0.9% | 8,230 | +1.2% | 0.06% | -3.1% |
| Q2 2016 | $352,000 | +4.1% | 8,130 | -2.4% | 0.06% | 0.0% |
| Q1 2016 | $338,000 | -1.7% | 8,330 | -2.3% | 0.06% | -3.0% |
| Q4 2015 | $344,000 | +4.9% | 8,530 | 0.0% | 0.07% | 0.0% |
| Q3 2015 | $328,000 | -7.6% | 8,530 | 0.0% | 0.07% | +3.1% |
| Q2 2015 | $355,000 | -9.9% | 8,530 | 0.0% | 0.06% | -12.2% |
| Q1 2015 | $394,000 | +7.9% | 8,530 | 0.0% | 0.07% | +5.7% |
| Q4 2014 | $365,000 | +13.4% | 8,530 | +21.9% | 0.07% | +7.7% |
| Q3 2014 | $322,000 | -19.7% | 7,000 | -6.7% | 0.06% | -19.8% |
| Q2 2014 | $401,000 | 0.0% | 7,500 | 0.0% | 0.08% | -3.6% |
| Q1 2014 | $401,000 | +0.2% | 7,500 | 0.0% | 0.08% | -3.4% |
| Q4 2013 | $400,000 | +6.4% | 7,500 | 0.0% | 0.09% | -13.0% |
| Q3 2013 | $376,000 | +7.4% | 7,500 | +7.1% | 0.10% | +9.9% |
| Q2 2013 | $350,000 | – | 7,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |